Vivani Medical (NASDAQ:VANI) versus Biostar Pharmaceuticals (OTCMKTS:BSPM) Critical Survey

Vivani Medical (NASDAQ:VANI) and Biostar Pharmaceuticals (OTCMKTS:BSPM) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk and valuation.

Volatility & Risk

Vivani Medical has a beta of 2.33, indicating that its stock price is 133% more volatile than the S&P 500. Comparatively, Biostar Pharmaceuticals has a beta of 71.78, indicating that its stock price is 7,078% more volatile than the S&P 500.

Institutional and Insider Ownership

6.8% of Vivani Medical shares are owned by institutional investors. 53.3% of Vivani Medical shares are owned by insiders. Comparatively, 17.2% of Biostar Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Vivani Medical and Biostar Pharmaceuticals”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$26.61 million	($0.40)	-3.29
Biostar Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Profitability

This table compares Vivani Medical and Biostar Pharmaceuticals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-264.04%	-79.85%
Biostar Pharmaceuticals	N/A	N/A	N/A

Analyst Ratings

This is a summary of recent recommendations for Vivani Medical and Biostar Pharmaceuticals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	1	1	2	0	2.25
Biostar Pharmaceuticals	0	0	0	0	0.00

Vivani Medical currently has a consensus price target of $3.75, indicating a potential upside of 185.17%. Given Vivani Medical’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Vivani Medical is more favorable than Biostar Pharmaceuticals.

Summary

Vivani Medical beats Biostar Pharmaceuticals on 5 of the 8 factors compared between the two stocks.

About Vivani Medical

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

About Biostar Pharmaceuticals

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.